In the current study, MIR22HG shares the binding sites with miR-629-5p, a miRNA whose expression is upregulated in osteosarcoma, and further results from Pearson’s correlation test suggests the negative correlation between miR-629-5p and MIR22HG. This evidence concerns the gene MIR22HG and osteosarcoma.